Dyne Therapeutics, Inc. DYN Available For Sale Securities Debt Securities Current
Available For Sale Securities Debt Securities Current at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dyne Therapeutics, Inc.'s available for sale securities debt securities current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dyne Therapeutics, Inc.'s available for sale securities debt securities current?
- Dyne Therapeutics, Inc. (DYN) reported available for sale securities debt securities current of $219.05M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s available for sale securities debt securities current changed year-over-year?
- Dyne Therapeutics, Inc.'s available for sale securities debt securities current increased by 6.7% year-over-year, from $205.24M to $219.05M.
- What is the long-term trend for Dyne Therapeutics, Inc.'s available for sale securities debt securities current?
- Over 5 years (2020 to 2025), Dyne Therapeutics, Inc.'s available for sale securities debt securities current has grown at a 37.3% compound annual growth rate (CAGR), from $44.46M to $217.19M.